Microarrays Beyond Reach

Using the subheading "Microarray tools open genomes to discoverers" in the Jan. 22 Hot Papers article1 is much like telling a group of kindergartners: "Any of you can become the president of the United States." The fact is most of them will never be the president no matter how hard they try. Microarrays are excellent tools, but their exorbitant price makes them beyond the reach of most researchers. The few papers that have been published so far using the "chips" came from either rich labs or lab

Written bySailen Barik
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Using the subheading "Microarray tools open genomes to discoverers" in the Jan. 22 Hot Papers article1 is much like telling a group of kindergartners: "Any of you can become the president of the United States." The fact is most of them will never be the president no matter how hard they try. Microarrays are excellent tools, but their exorbitant price makes them beyond the reach of most researchers. The few papers that have been published so far using the "chips" came from either rich labs or labs that have industrial/proprietary connections.

I don't think the microarray hot papers of today will remain hot for long. They were neither conceptually novel nor hard to do; they simply represent "proof of concept" or application of a great but easy technology. They are much like papers that used PCR when PCR was new. But at least PCR was inexpensive and, thus, the playing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo